{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:27:02Z","timestamp":1786678022321,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtocrr.2026.101026","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:39:34Z","timestamp":1780331974000},"page":"101026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Akihiro","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushiro","family":"Ohtsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2026.101026_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.jtocrr.2026.101026_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2183\/pjab.98.008","article-title":"RET receptor signaling: function in development, metabolic disease, and cancer","volume":"98","author":"Takahashi","year":"2022","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.jtocrr.2026.101026_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc3680","article-title":"RET revisited: expanding the oncogenic portfolio","volume":"14","author":"Mulligan","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtocrr.2026.101026_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/cas.12941","article-title":"Gene aberrations for precision medicine against lung adenocarcinoma","volume":"107","author":"Saito","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtocrr.2026.101026_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2026.101026_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO-24-02076","article-title":"Selpercatinib in RET fusion-positive non-small cell lung cancer: final safety and efficacy, including overall survival, from the LIBRETTO-001 phase I\/II trial","volume":"43","author":"Gautschi","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtocrr.2026.101026_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.22.00393","article-title":"Selpercatinib in patients with RET fusion-positive non-small cell lung cancer: updated safety and efficacy from the registrational LIBRETTO-011 phase I\/II trial","volume":"41","author":"Drilon","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumor-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-011): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","article-title":"Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-25-4382","article-title":"Landscape of genomic mechanisms of resistance to selective RET inhibitors in RET-altered solid tumors: analysis of the RETgistry global consortium","volume":"32","author":"Waliany","year":"2026","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2026.101026_bib12","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/JTO.0b013e3182721ed1","article-title":"Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2\/ad","volume":"7","author":"Matsubara","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/molpharm.120.000207","article-title":"Novel human-derived RET fusion NSCLC cell lines have heterogeneous responses to RET inhibitors and differential regulation of downstream signaling","volume":"99","author":"Schubert","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib14","article-title":"RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation","volume":"14","author":"Hayashi","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jtocrr.2026.101026_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cas.12600","article-title":"In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line","volume":"106","author":"Nanjo","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtocrr.2026.101026_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41698-024-00706-7","article-title":"Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition","volume":"8","author":"Corti","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtocrr.2026.101026_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ijc.29858","article-title":"Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer","volume":"138","author":"Takeuchi","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtocrr.2026.101026_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/1535-7163.MCT-16-0522","article-title":"MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer","volume":"16","author":"Nanjo","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtocrr.2026.101026_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217220","article-title":"MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer","volume":"604","author":"Wei","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtocrr.2026.101026_bib21","doi-asserted-by":"crossref","first-page":"73766","DOI":"10.18632\/oncotarget.17900","article-title":"In vivo and in vitro anti-tumor activity of alectinib in tumor cells with NCOA4-RET","volume":"8","author":"Arai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtocrr.2026.101026_bib22","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1038\/s41598-017-05931-8","article-title":"Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells","volume":"7","author":"Fujikawa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtocrr.2026.101026_bib23","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1158\/1078-0432.CCR-21-3622","article-title":"HSP90 inhibition overcomes resistance to molecular targeted therapy in BRAFV600E-mutant high-grade glioma","volume":"28","author":"Sasame","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2026.101026_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00021","article-title":"Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases","volume":"3","author":"Guo","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jtho.2017.10.021","article-title":"Clinical and translational implications of RET rearrangements in non-small cell lung cancer","volume":"13","author":"Ferrara","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2026.101026_bib26","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1535-7163.MCT-15-0350","article-title":"Antitumor activity and acquired resistance mechanism of dovitinib (TKI258) in RET-rearranged lung adenocarcinoma","volume":"14","author":"Kang","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtocrr.2026.101026_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174643","article-title":"The genomic landscape of lung cancer in never-smokers from the Women\u2019s Health Initiative","volume":"9","author":"Moorthi","year":"2024","journal-title":"JCI Insight"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364326000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364326000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T02:32:33Z","timestamp":1786674753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364326000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666364326000779"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2026.101026","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2026.101026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"101026"}}